Sharecare, Inc. (NASDAQ:SHCR) Q2 2022 Earnings Conference Call August 10, 2022 8:00 AM ET Company Participants Evan Smith - Senior Vice President of Finance & Investor Relations Jeff Arnold - Chairman & Chief Executive Officer Justin Ferrero - President & Chief Financial Officer Conference Call Participants Craig Hettenbach - Morgan Stanley David Larsen - BTIG Eric Percher - Nephron Research Richard Close - Canaccord Genuity Cindy Motz - Goldman Sachs Operator Good day, and welcome to the Sharecare Second Q ...

| --- | --- | --- | --- | --- | --- | --- | |-----------|--------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | D | | | | | | | | sharecare | | | | | | | | better | All together | | | | | | Important Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. I ...

OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________ FORM 10-Q _____________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 (Address of Principal Executive Offices) (Zip Code) 3030 ...

Sharecare, Inc. (NASDAQ:SHCR) Q1 2022 Earnings Conference Call May 12, 2022 8:00 AM ET Company Participants Evan Smith - Senior Vice President of Finance & Investor Relations Jeff Arnold - Founder, Chairman & Chief Executive Officer Justin Ferrero - President & Chief Financial Officer Conference Call Participants Richard Close - Canaccord David Larsen - BTIG Cindy Motz - Goldman Sachs Eric Percher - Nephron Research Operator Good day and thank you for standing by. Welcome to the Sharecare First Quarter 2022 ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K _____________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39535 SHARECARE, INC. (Exact name of registrant as specified in its ...

Financial Data and Key Metrics Changes - Sharecare reported a 26% year-over-year revenue growth, reaching $413 million, and delivered $27 million in positive adjusted EBITDA for the fiscal year 2021 [6][21] - Fourth quarter revenue grew 34% to $118.5 million from $88.4 million a year ago [21] - Adjusted EBITDA for the fourth quarter was $5.4 million, reflecting positive performance across the business [22] Business Line Data and Key Metrics Changes - The revenue growth was primarily driven by Life Sciences, CareLinx, health security, and new client wins across the platform [22] - The record retrievable business for payers and providers retrieved approximately five million records in fiscal 2021, a 19% increase over the prior year [19] - In Payment Integrity, over $6 billion in claims were processed, identifying over $100 million in overpayments [19] Market Data and Key Metrics Changes - Sharecare's platform now helps nearly 10 million employees, plan members, and patients [10] - Eligible lives on the platform grew to approximately 9.7 million, with potential serviceable lives increasing to 91 million across existing contracted client populations [18] - The company expects to increase eligible lives to approximately 12 million by year-end fiscal 2022, a 24% increase over fiscal 2021 [26] Company Strategy and Development Direction - Sharecare is focusing on expanding its core platform to drive higher PMPMs and broader patient engagement [14] - The company has decided to suspend support for its vaccine assistant and health passport solutions, which were not meeting long-term growth hurdles [9][16] - Sharecare is committed to optimizing capital allocation and resources to deliver the highest long-term revenue growth and profitability [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in delivering strong year-over-year revenue growth and solid adjusted EBITDA performance while building a strong run rate for fiscal 2023 [28] - The company anticipates a majority of adjusted EBITDA guidance will occur in the third and fourth quarters of 2022 [25] - Management highlighted a strong pipeline for 2023, with a 4x to 5x increase year-over-year in pipeline opportunities [57] Other Important Information - Sharecare ended the year with no debt and over $300 million in liquidity to support future growth and profitability [6] - The company is investing heavily in product and technology, as well as sales force expansion, to support long-term growth [22][73] Q&A Session Summary Question: Can you talk about the vaccine assistant and health passport decision? - Management indicated that the decision to move away from these businesses was based on changing market conditions and feedback from investors to simplify the business model [33][34] Question: Why is there a material impact to earnings contribution in '22 with the transition to a tech-enabled solution? - Management explained that the patient-centered medical home model had started losing money, prompting a transition to a tech-enabled model to improve profitability [35][36] Question: How much of the $2 million to $3 million contingency revenue would have dropped to adjusted EBITDA? - Almost all of it would have dropped to the bottom line had an accrual-based accounting methodology been used [45] Question: What is the expected growth for Life Sciences? - Life Sciences revenue grew from $61 million to $78 million from 2020 to 2021, with an expected growth of approximately 11% for 2022 [59] Question: How is the sales team compensated? - The sales team is heavily incentivized on commission, aligning their success with the company's performance [86]

All together better Confidential and proprietary document by Sharecare, Inc. Dates and materials are subject to change. 1 Important Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: "outlook," "target," "reflect," "on t ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________ FORM 10-Q _____________________________________________ x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-39535 SHARECARE, INC. (Ex ...

Sharecare, Inc. (NASDAQ:SHCR) Q3 2021 Earnings Conference Call November 10, 2021 8:00 AM ET Company Participants Jeff Arnold – Chairman and Chief Executive Officer Justin Ferrero – President and Chief Financial Officer Conference Call Participants Eric Percher – Nephron Research Richard Close – Canaccord Genuity Ben Sherlund – Cantor Fitzgerald David Larsen – BTIG Operator Good morning and welcome to Sharecare's Third Quarter 2021 Earnings Conference Call and Webcast. All participants will be in a listening ...

Morgan Stanley and and and the states of the st sharecare All together better Important Notice Regarding Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: "outlook," "target," "reflect," "on track," "foresees," "future," "may," "deliver ...